Cargando…

Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells

Background: Lung cancer is the leading cause of cancer death worldwide. More effective treatments are needed to increase durable responses and prolong patient survival. Standard of care treatment for patients with non-operable stage III-IV NSCLC is concurrent chemotherapy and radiation. An activated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosa Iglesias, Venus, Theys, Jan, Groot, Arjan J., Barbeau, Lydie M. O., Lemmens, Alyssa, Yaromina, Ala, Losen, Mario, Houben, Ruud, Dubois, Ludwig, Vooijs, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234899/ https://www.ncbi.nlm.nih.gov/pubmed/30464927 http://dx.doi.org/10.3389/fonc.2018.00460

Ejemplares similares

Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis
por: Moreno Roig, Eloy, et al.
Publicado: (2018)

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
por: Sosa Iglesias, Venus, et al.
Publicado: (2018)

NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma
por: Yahyanejad, Sanaz, et al.
Publicado: (2016)

HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells
por: Moreno Roig, Eloy, et al.
Publicado: (2019)

Targeting Notch to overcome radiation resistance
por: Yahyanejad, Sanaz, et al.
Publicado: (2015)

Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)

NOTCH inhibition promotes bronchial stem cell renewal and epithelial barrier integrity after irradiation
por: Giuranno, Lorena, et al.
Publicado: (2020)

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Gamma secretase inhibitors of Notch signaling
por: Olsauskas-Kuprys, Roma, et al.
Publicado: (2013)

Polyphenols as Potential Protectors against Radiation-Induced Adverse Effects in Patients with Thoracic Cancer
por: Prades-Sagarra, Èlia, et al.
Publicado: (2023)

In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity
por: Panth, Kranthi Marella, et al.
Publicado: (2016)

Epidermal ADAM17 is dispensable for Notch activation
por: Groot, Arjan J., et al.
Publicado: (2013)

A lineage-tracing tool to map the fate of hypoxic tumour cells
por: Vermeer, Jenny A. F., et al.
Publicado: (2020)

Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
por: van der Wiel, Alexander M. A., et al.
Publicado: (2022)

The Role of Intracellular Trafficking of Notch Receptors in Ligand-Independent Notch Activation
por: Hounjet, Judith, et al.
Publicado: (2021)

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Monoubiquitination and endocytosis direct γ-secretase cleavage of activated Notch receptor
por: Gupta-Rossi, Neetu, et al.
Publicado: (2004)

Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?
por: Clementz, Anthony G, et al.
Publicado: (2009)

Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape
por: Hamis, Sara, et al.
Publicado: (2020)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020)

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
por: Olivo Pimentel, Veronica, et al.
Publicado: (2021)

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
por: Hiddingh, Lotte, et al.
Publicado: (2013)

Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma
por: Abedin, Yasmin, et al.
Publicado: (2022)

Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats
por: Chen, Yixiong, et al.
Publicado: (2012)

γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
por: Mizugaki, H, et al.
Publicado: (2012)

NOTCH2 gene mutation and gamma-secretase inhibitor in mediating the malignancy of ovarian cancer
por: Wang, Wenjing, et al.
Publicado: (2023)

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
por: Marcus, Damiënne, et al.
Publicado: (2021)

Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
por: Sparling, David P., et al.
Publicado: (2015)

Sanpodo controls sensory organ precursor fate by directing Notch trafficking and binding γ-secretase
por: Upadhyay, Alok, et al.
Publicado: (2013)

γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets
por: Dorneburg, Carmen, et al.
Publicado: (2016)

Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer
por: Feng, Zhaoyi, et al.
Publicado: (2016)

Sustained notch signaling inhibition with a gamma-secretase inhibitor prevents traumatic heterotopic ossification
por: Wang, Zheng, et al.
Publicado: (2023)

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
por: O'Neil, Jennifer, et al.
Publicado: (2007)

Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma
por: Guo, Zhen, et al.
Publicado: (2013)

γ‐secretase inhibitor DAPT mitigates cisplatin‐induced acute kidney injury by suppressing Notch1 signaling
por: Soni, Hitesh, et al.
Publicado: (2018)

Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors
por: Mamaeva, Veronika, et al.
Publicado: (2016)

Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2021)

Notch signaling inactivation by small molecule γ-secretase inhibitors restores the multiciliated cell population in the airway epithelium
por: Vladar, Eszter K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fn80jtc36039kbidc0ic9f2hmr